Skip to main content
OpenTrials
Completed

NCT Number: NCT03364543

The UTHealth Medical-Legal Partnership: Improving Health by Addressing Health-Harming Legal Needs

The purpose of this study is to assess the acceptability, feasibility, and preliminary effectiveness of the UTHealth medical-legal partnerships (MLP) against usual care.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

The University of Texas Health Science Center at Houston, Houston, Texas, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • English- or Spanish- speaking
  • screen positive for health-harming legal needs (HHLNs)

Exclusion criteria

  • Those unable or unwilling to consent to legal services

Treatment and study plan

Access to the Medical-Legal Partnership Group

Other

The Medical-Legal Partnership Group are lawyers in clinics who address health-harming legal needs.

Access to social worker and a community worker

Other

Access to social worker and a community worker, but no systematic process for addressing health-harming legal needs.

Primary outcomes

  1. Number of participants who had an emergency department visit

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

The University of Texas Health Science Center, Houston

Other

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Dec 6, 2017
Registry last updated
Nov 6, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.